Retrospective analysis of hepatic arterial infusion chemotherapy for patients with unresectable liver metastases from colorectal cancer refractory to current standard systemic chemotherapy

Retrospective analysis of hepatic arterial infusion chemotherapy for patients with unresectable liver metastases from colorectal cancer refractory to current standard systemic chemotherapy - Analysis of HAIC for liver metastases from colorectal cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000020878

Enrollment

150

Registered

2016-02-04

Start date

2016-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver metastases from colorectal cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients with unresectable liver metastases from colorectal cancer 2) Patients who had undergone standard systemic chemotherapy for advanced or metastatic colorectal cancer 3) Patients receiving hepatic hepatic arterial infusion chemotherapy after standard systemic chemotherapy

Exclusion criteria

Exclusion criteria: 1) Active double cancers

Design outcomes

Primary

Measure	Time frame
Overall survival time from initiation of hepatic arterial infusion chemotherapy	—

Countries

Japan

Contacts

Public ContactYozo Sato

Aichi Cancer Center Hospital Department of Diagnostic and Interventional Radiology

ysato@aichi-cc.jp052-762-6111

Outcome results